Diagenode Diagnostics logo

News

Diagenode S.A. obtains the rights to the patents covering the detection of Norwalk-like Virus I and II
April 6, 2017

Effective as of January 1, 2017, Diagenode S.A. obtains the rights to the patents covering the detection of Norwalk-like Virus I and II:US patent No. 7,202,032, EP patent No. 1329522, US patent No. 7,351,819 and EP patent No. 1329523 under licensing agreement.

© 2017 – Diagenode Diagnostics | ISO 9001 - ISO 13485 | Site Map | Privacy policy | Contact Us | Terms and Conditions |